Page 1 | Search Results | Diabetes Care | American Diabetes Association

1-20 of 26

Sort by

Sort Order Select

Journal Articles

Prediction of Diabetes Based on Baseline Metabolic Characteristics in Individuals at High Risk

Ralph A. DeFronzo, MD, Devjit Tripathy, MD, Dawn C. Schwenke, PHD, MaryAnn Banerji, MD, George A. Bray, MD, Thomas A. Buchanan, MD, Stephen C. Clement, MD, Robert R. Henry, MD, Abbas E. Kitabchi, PHD, Sunder Mudaliar, MD, Robert E. Ratner, MD, Frankie B. Stentz, MS, Nicolas Musi, MD, Peter D. Reaven, MD, Amalia Gastaldelli, PHD, for the ACT NOW Study

Diabetes Care 2013;36(11):3607–3612

https://doi.org/10.2337/dc13-0520

Published: 15 October 2013

View article titled, Prediction of Diabetes Based on Baseline Metabolic Characteristics in Individuals at High Risk

Journal Articles

Scientific Statement: Socioecological Determinants of Prediabetes and Type 2 Diabetes

James O. Hill, PHD, James M. Galloway, MD, April Goley, RN, MSN, FNP-C, David G. Marrero, PHD, Regan Minners, BA, Brenda Montgomery, RN, MS, CDE, Gregory E. Peterson, DO, Robert E. Ratner, MD, Eduardo Sanchez, MD, MPH, Vanita R. Aroda, MD

Diabetes Care 2013;36(8):2430–2439

https://doi.org/10.2337/dc13-1161

Published: 11 July 2013

View article titled, Scientific Statement: Socioecological Determinants of Prediabetes and Type 2 Diabetes

Includes: Supplementary data

Journal Articles

The Imperative to Prevent Diabetes

Robert E. Ratner, MD

Diabetes Care 2012;35(12):2417–2418

https://doi.org/10.2337/dc12-1997

Published: 14 November 2012

View article titled, The Imperative to Prevent Diabetes

Journal Articles

Skin Intrinsic Fluorescence Is Associated With Coronary Artery Disease in Individuals With Long Duration of Type 1 Diabetes

Baqiyyah N. Conway, PHD, Vanita R. Aroda, MD, John D. Maynard, MS, Nathaniel Matter, PHD, Stephen Fernandez, MPH, Robert E. Ratner, MD, Trevor J. Orchard, MD

Diabetes Care 2012;35(11):2331–2336

https://doi.org/10.2337/dc12-0053

Published: 13 October 2012

View article titled, Skin Intrinsic Fluorescence Is Associated With Coronary Artery Disease in Individuals With Long Duration of Type 1 Diabetes

Journal Articles

The American Diabetes Association Diabetes Research Perspective

Vivian A. Fonseca, MD, M. Sue Kirkman, MD, Tamara Darsow, PHD, Robert E. Ratner, MD

Diabetes Care 2012;35(6):1380–1387

https://doi.org/10.2337/dc12-9001

Published: 11 May 2012

View article titled, The American Diabetes Association Diabetes Research Perspective

Journal Articles

Skin Intrinsic Fluorescence Correlates With Autonomic and Distal Symmetrical Polyneuropathy in Individuals With Type 1 Diabetes

Baqiyyah N. Conway, PHD, Vanita R. Aroda, MD, John D. Maynard, MS, Nathaniel Matter, PHD, Stephen Fernandez, MPH, Robert E. Ratner, MD, Trevor J. Orchard, MD

Diabetes Care 2011;34(4):1000–1005

https://doi.org/10.2337/dc10-1791

Published: 21 March 2011

View article titled, Skin Intrinsic Fluorescence Correlates With Autonomic and Distal Symmetrical Polyneuropathy in Individuals With Type 1 Diabetes

Includes: Supplementary data

Journal Articles

Diabetes Management in the Age of National Health Reform

Robert E. Ratner, MD

Diabetes Care 2011;34(4):1054–1057

https://doi.org/10.2337/dc10-1987

Published: 21 March 2011

View article titled, Diabetes Management in the Age of National Health Reform

Journal Articles

Insulin Degludec in Type 1 Diabetes: A randomized controlled trial of a new-generation ultra-long-acting insulin compared with insulin glargine

Kåre I. Birkeland, MD, Philip D. Home, DM, Ulrich Wendisch, MD, Robert E. Ratner, MD, Thue Johansen, MD, Lars A. Endahl, PHD, Karsten Lyby, MSC, Johan H. Jendle, MD, Anthony P. Roberts, MD, J. Hans DeVries, MD, Luigi F. Meneghini, MD

Diabetes Care 2011;34(3):661–665

https://doi.org/10.2337/dc10-1925

Published: 17 February 2011

View article titled, Insulin Degludec in Type 1 Diabetes: <subtitle>A randomized controlled trial of a new-generation ultra-long-acting insulin compared with insulin glargine</subtitle>

Includes: Supplementary data

Journal Articles

Treatment With the Human Once-Weekly Glucagon-Like Peptide-1 Analog Taspoglutide in Combination With Metformin Improves Glycemic Control and Lowers Body Weight in Patients With Type 2 Diabetes Inadequately Controlled With Metformin Alone: A double-blind placebo-controlled study

Michael A. Nauck, MD, Robert E. Ratner, MD, Christoph Kapitza, MD, Rachele Berria, MD, Mark Boldrin, Raffaella Balena, MD, PHD

Diabetes Care 2009;32(7):1237–1243

https://doi.org/10.2337/dc08-1961

Published: 14 April 2009

View article titled, Treatment With the Human Once-Weekly Glucagon-Like Peptide-1 Analog Taspoglutide in Combination With Metformin Improves Glycemic Control and Lowers Body Weight in Patients With Type 2 Diabetes Inadequately Controlled With Metformin Alone: <subtitle>A double-blind placebo-controlled study</subtitle>

Includes: Supplementary data

Journal Articles

Effect of Progression From Impaired Glucose Tolerance to Diabetes on Cardiovascular Risk Factors and Its Amelioration by Lifestyle and Metformin Intervention: The Diabetes Prevention Program randomized trial by the Diabetes Prevention Program Research Group

Ronald B. Goldberg, MD, Marinella Temprosa, MS, Steven Haffner, MD, Trevor J. Orchard, MD, Robert E. Ratner, MD, Sarah E. Fowler, PHD, Kieren Mather, MD, Santica Marcovina, PHD, Chris Saudek, MD, Margaret J. Matulik, MS, David Price, MD

Diabetes Care 2009;32(4):726–732

https://doi.org/10.2337/dc08-0494

Published: 26 January 2009

View article titled, Effect of Progression From Impaired Glucose Tolerance to Diabetes on Cardiovascular Risk Factors and Its Amelioration by Lifestyle and Metformin Intervention: <subtitle>The Diabetes Prevention Program randomized trial by the Diabetes Prevention Program Research Group</subtitle>

Includes: Supplementary data

Journal Articles

Cost-Effectiveness of Screening for Pre-Diabetes Among Overweight and Obese U.S. Adults: Response to Wechowski

Thomas J. Hoerger, PHD, Katherine A. Hicks, MS, Stephen W. Sorensen, PHD, William H. Herman, MD, MPH, Robert E. Ratner, MD, Ronald T. Ackermann, MD, MPH, Ping Zhang, PHD, Michael M. Engelgau, MD

Diabetes Care 2008;31(5):e35

https://doi.org/10.2337/dc08-0096

Published: 01 May 2008

View article titled, Cost-Effectiveness of Screening for Pre-Diabetes Among Overweight and Obese U.S. Adults: <subtitle>Response to Wechowski</subtitle>

Journal Articles

Cost-Effectiveness of Screening for Pre-Diabetes Among Overweight and Obese U.S. Adults

Thomas J. Hoerger, PHD, Katherine A. Hicks, MS, Stephen W. Sorensen, PHD, William H. Herman, MD, MPH, Robert E. Ratner, MD, Ronald T. Ackermann, MD, MPH, Ping Zhang, PHD, Michael M. Engelgau, MD

Diabetes Care 2007;30(11):2874–2879

https://doi.org/10.2337/dc07-0885

Published: 01 November 2007

View article titled, Cost-Effectiveness of Screening for Pre-Diabetes Among Overweight and Obese U.S. Adults

Includes: Supplementary data

Journal Articles

Resolution of Asymptomatic Myocardial Ischemia in Patients With Type 2 Diabetes in the Detection of Ischemia in Asymptomatic Diabetics (DIAD) Study

Frans J. Th. Wackers, MD, Deborah A. Chyun, PHD, Lawrence H. Young, MD, Gary V. Heller, MD, Ami E. Iskandrian, MD, Janice A. Davey, MSN, Eugene J. Barrett, MD, Raymond Taillefer, MD, Steven D. Wittlin, MD, Neil Filipchuk, MD, Robert E. Ratner, MD, Silvio E. Inzucchi, MD, for the Detection of Ischemia in Asymptomatic Diabetics (DIAD) Investigators

Diabetes Care 2007;30(11):2892–2898

https://doi.org/10.2337/dc07-1250

Published: 01 November 2007

View article titled, Resolution of Asymptomatic Myocardial Ischemia in Patients With Type 2 Diabetes in the Detection of Ischemia in Asymptomatic Diabetics (DIAD) Study

Journal Articles

Prevention of Type 2 Diabetes in Women With Previous Gestational Diabetes

Robert E. Ratner, MD

Diabetes Care 2007;30(Supplement_2):S242–S245

https://doi.org/10.2337/dc07-s223

Published: 01 July 2007

View article titled, Prevention of Type 2 Diabetes in Women With Previous Gestational Diabetes

Journal Articles

An Evaluation of Cost Sharing to Finance a Diet and Physical Activity Intervention to Prevent Diabetes

Ronald T. Ackermann, MD, MPH, David G. Marrero, PHD, Katherine A. Hicks, MS, Thomas J. Hoerger, PHD, Stephen Sorensen, PHD, Ping Zhang, PHD, Michael M. Engelgau, MD, MS, Robert E. Ratner, MD, William H. Herman, MD, MPH

Diabetes Care 2006;29(6):1237–1241

https://doi.org/10.2337/dc05-1709

Published: 01 June 2006

View article titled, An Evaluation of Cost Sharing to Finance a Diet and Physical Activity Intervention to Prevent Diabetes

Includes: Supplementary data

Journal Articles

Achievement of American Diabetes Association Clinical Practice Recommendations Among U.S. Adults With Diabetes, 1999–2002: The National Health and Nutrition Examination Survey

Helaine E. Resnick, PHD, MPH, Gregory L. Foster, MA, Joan Bardsley, RN, CDE, Robert E. Ratner, MD

Diabetes Care 2006;29(3):531–537

https://doi.org/10.2337/diacare.29.03.06.dc05-1254

Published: 01 March 2006

View article titled, Achievement of American Diabetes Association Clinical Practice Recommendations Among U.S. Adults With Diabetes, 1999–2002: <subtitle>The National Health and Nutrition Examination Survey</subtitle>

Includes: Supplementary data

Journal Articles

Coronary Heart Disease Risk Equivalence in Diabetes Depends on Concomitant Risk Factors

Barbara V. Howard, PHD, Lyle G. Best, MD, James M. Galloway, MD, William James Howard, MD, Kristina Jones, MPH, Elisa T. Lee, PHD, Robert E. Ratner, MD, Helaine E. Resnick, MPH, PHD, Richard B. Devereux, MD

Diabetes Care 2006;29(2):391–397

https://doi.org/10.2337/diacare.29.02.06.dc05-1299

Published: 01 February 2006

View article titled, Coronary Heart Disease Risk Equivalence in Diabetes Depends on Concomitant Risk Factors

Journal Articles

Effects of Exenatide (Exendin-4) on Glycemic Control and Weight Over 30 Weeks in Metformin-Treated Patients With Type 2 Diabetes

Ralph A. DeFronzo, MD, Robert E. Ratner, MD, Jenny Han, MS, Dennis D. Kim, MD, Mark S. Fineman, BS, Alain D. Baron, MD

Diabetes Care 2005;28(5):1092–1100

https://doi.org/10.2337/diacare.28.5.1092

Published: 01 May 2005

View article titled, Effects of Exenatide (Exendin-4) on Glycemic Control and Weight Over 30 Weeks in Metformin-Treated Patients With Type 2 Diabetes

Journal Articles

Detection of Silent Myocardial Ischemia in Asymptomatic Diabetic Subjects: The DIAD study

Frans J.Th. Wackers, MD, Lawrence H. Young, MD, Silvio E. Inzucchi, MD, Deborah A. Chyun, PHD, Janice A. Davey, MSN, Eugene J. Barrett, MD, Raymond Taillefer, MD, Steven D. Wittlin, MD, Gary V. Heller, MD, Neil Filipchuk, MD, Samuel Engel, MD, Robert E. Ratner, MD, Ami E. Iskandrian, MD, for the Detection of Ischemia in Asymptomatic Diabetics (DIAD) Investigators

Diabetes Care 2004;27(8):1954–1961

https://doi.org/10.2337/diacare.27.8.1954

Published: 01 August 2004

View article titled, Detection of Silent Myocardial Ischemia in Asymptomatic Diabetic Subjects: <subtitle>The DIAD study </subtitle>

Journal Articles

Impact of Computer-Generated Personalized Goals on HbA_1c

Claresa S. Levetan, MD, Karen R. Dawn, RN, CDE, David C. Robbins, MD, Robert E. Ratner, MD

Diabetes Care 2002;25(1):2–8

https://doi.org/10.2337/diacare.25.1.2

Published: 01 January 2002

View article titled, Impact of Computer-Generated Personalized Goals on HbA<sub>1c</sub>

NARROW

Prediction of Diabetes Based on Baseline Metabolic Characteristics in Individuals at High Risk

Scientific Statement: Socioecological Determinants of Prediabetes and Type 2 Diabetes

The Imperative to Prevent Diabetes

Skin Intrinsic Fluorescence Is Associated With Coronary Artery Disease in Individuals With Long Duration of Type 1 Diabetes

The American Diabetes Association Diabetes Research Perspective

Skin Intrinsic Fluorescence Correlates With Autonomic and Distal Symmetrical Polyneuropathy in Individuals With Type 1 Diabetes

Diabetes Management in the Age of National Health Reform

Insulin Degludec in Type 1 Diabetes: A randomized controlled trial of a new-generation ultra-long-acting insulin compared with insulin glargine

Treatment With the Human Once-Weekly Glucagon-Like Peptide-1 Analog Taspoglutide in Combination With Metformin Improves Glycemic Control and Lowers Body Weight in Patients With Type 2 Diabetes Inadequately Controlled With Metformin Alone: A double-blind placebo-controlled study

Effect of Progression From Impaired Glucose Tolerance to Diabetes on Cardiovascular Risk Factors and Its Amelioration by Lifestyle and Metformin Intervention: The Diabetes Prevention Program randomized trial by the Diabetes Prevention Program Research Group

Cost-Effectiveness of Screening for Pre-Diabetes Among Overweight and Obese U.S. Adults: Response to Wechowski

Cost-Effectiveness of Screening for Pre-Diabetes Among Overweight and Obese U.S. Adults

Resolution of Asymptomatic Myocardial Ischemia in Patients With Type 2 Diabetes in the Detection of Ischemia in Asymptomatic Diabetics (DIAD) Study

Prevention of Type 2 Diabetes in Women With Previous Gestational Diabetes

An Evaluation of Cost Sharing to Finance a Diet and Physical Activity Intervention to Prevent Diabetes

Achievement of American Diabetes Association Clinical Practice Recommendations Among U.S. Adults With Diabetes, 1999–2002: The National Health and Nutrition Examination Survey

Coronary Heart Disease Risk Equivalence in Diabetes Depends on Concomitant Risk Factors

Effects of Exenatide (Exendin-4) on Glycemic Control and Weight Over 30 Weeks in Metformin-Treated Patients With Type 2 Diabetes

Detection of Silent Myocardial Ischemia in Asymptomatic Diabetic Subjects: The DIAD study

Impact of Computer-Generated Personalized Goals on HbA_1c

Email alerts

Journals

Books

Clinical Compendia

News

Other

About

Resources

Email alerts

Journals

Books

Clinical Compendia

News

Other

About

Resources

This Feature Is Available To Subscribers Only